Taysha Gene Therapies Inc (TSHA)
SG&A Expense Growth
25.51%
Quarterly · Period ending:
TSHA SG&A Expense Growth
Latest reported25.51%period ending
Latest reported25.51%period ending
TSHA Quarterly SG&A Growth (QoQ) (0.00% → 25.51%)
Latest values, visible window
High-resolution chart · PNG
TSHA sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 25.5141% | |
| 9.5551% | |
| 6.6916% | |
| -3.7102% | |
| 5.3935% | |
| 23.0653% | |
| -16.1098% | |
| 7.686% | |
| 3.5855% | |
| 5.4324% | |
| -18.6365% | |
| 56.2535% | |
| -34.9138% | |
| 43.4122% | |
| -34.7921% | |
| -11.9996% | |
| -13.9681% | |
| -2.8545% | |
| 5.8549% | |
| 10.1096% | |
| 22.9845% | |
| 34.8616% | |
| 53.2882% | |
| 320.2532% | |
| 1,254.2857% | |
| -45.3125% | |
| 0% |